Pharma ED Resources Inc. is organizing
Transdermal and Intradermal Drug Delivery Systems, 2016 Advanced Design, Development, and Delivery of Skin-Mediated Therapies and Vaccines
September 12-13 at the Racquet Club of Philadelphia
I attended this conference last year for the first time and I really enjoyed it. It’s a beautiful, but intimate venue in the heart of Philadelphia. The speakers and the audience questions were all excellent and I can’t wait for the next one.
I have the honor and distinct pleasure of addressing the audience three times on Monday afternoon (I’m going to need a lozenge). First, I’m going to give a presentation on Product Development Trends: Insourcing and Outsourcing. Later, I’ve got some remarks on the recent FDA Draft Guidance on Assessing Adhesion with Transdermal Delivery Systems and Topical Patches for ANDAs. Hopefully, we can generate some lively debate on the pros and cons of the draft. Keeping with the regulatory theme, but casting a wider net, Michael Eakins and I will again host an open-forum discussion on Regulatory Considerations for TDD & IDD Systems. This was a really interesting session last year that showed this topic is just as relevant to product developers as it is to our regulatory affairs partners.
If you have any interest in transdermal or intradermal systems, you really ought to be there.